No Data
No Data
Mesa Laboratories, Inc.: Expect to Record Non-Cash Impairment Losses Related to Clinical Genomics and Biopharmaceutical Development Divisions of About $271M During 4Q FY24 >MLAB
Mesa Laboratories, Inc.: Expect to Record Non-Cash Impairment Losses Related to Clinical Genomics and Biopharmaceutical Development Divisions of About $271M During 4Q FY24 >MLAB
Shareholders in Mesa Laboratories (NASDAQ:MLAB) Have Lost 60%, as Stock Drops 12% This Past Week
If you love investing in stocks you're bound to buy some losers. Long term Mesa Laboratories, Inc. (NASDAQ:MLAB) shareholders know that all too well, since the share price is down considerably over t
Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 39% Below Their Intrinsic Value Estimate
Mesa Laboratories (MLAB) Impacted by Slowdown in Pharmaceutical And Biotech Spending
Earnings Flash (MLAB) MESA LABORATORIES Reports Q3 EPS $2.02
08:04 AM EST, 02/05/2024 (MT Newswires) -- Earnings Flash (MLAB) MESA LABORATORIES Reports Q3 EPS $2.02
Spectaire Shares Rise On Distribution Agreement With MLab
No Data